Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

SECZ · NYSE

Securitize Corp.

$7.78 -0.21 (-2.63%)

Company overview

Securitize is a financial technology company that provides a platform for tokenizing real-world assets, enabling businesses to raise capital by issuing digital tokens on the blockchain. It operates a regulated end-to-end platform for the issuance, trading, and servicing of tokenized securities for top-tier asset managers like BlackRock and KKR. The company went public via a business combination with Cantor Equity Partners II.

Sector
Financial Services
Industry
Financial - Data & Stock Exchanges
Exchange
NYSE
Market cap
$1.3B
Employees
2
Headquarters
Miami, FL
Website
securitize.io
CEO
Carlos Domingo
Listed
July 2, 2026
P/E
0.00
Dividend yield
0.00%

Price chart

4.677.8711.0814.2817.48
SECZ 1D NYSE O7.87H8.23L7.71C7.76-0.21 (-2.63%)Vol735.62K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
SECZ Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Securitize Corp. - SECZ ACCESS Newswire
SECZ Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Securitize Corp. - SECZ ACCESS Newswire
SECZ Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Securitize Corp. - SECZ ACCESS Newswire
SECZ Stock news Securitize's Blockchain Ambitions Face a Reality Check MarketBeat
SECZ Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Securitize Corp. - SECZ Pomerantz LLP is investigating claims on behalf of investors of Securitize Corp.("Securitize" or the "Company") (NYSE:SECZ). PR Newswire
SECZ Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Securitize Corp. - SECZ ACCESS Newswire
SECZ Stock news Apple, Nvidia, and Tesla Shares Now Trade on Solana: Why Did Securitize Choose Solana Over Ethereum? 247 Wallst
SECZ Press release Securitize Launches Global Onchain Trading of U.S. Stocks with Security Entitlements PRNewsWire
SECZ Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Securitize Corp. – SECZ GlobeNewsWire
SECZ Press release Securitize and LG CNS Partner to Advance Tokenized Assets in South Korea PRNewsWire
SECZ Press release Securitize Integrates with ADI Chain to Expand Institutional Tokenization Across Global Markets PRNewsWire
SECZ Press release ARK Invest Tokenizes ARK Venture Fund (ARKVX) with Securitize PR Newswire
SECZ Stock news Here's why Securitize stock is rising and the potential risks Invezz
SECZ Legal SECZ Investors Have Opportunity to Join Securitize Corp. Fraud Investigation with SBS Law GuruFocus
SECZ Press release Dubai's Virtual Assets Regulatory Authority and Securitize Sign Memorandum of Understanding to Advance Regulated Tokenised Markets PRNewsWire
SECZ Press release Securitize and Neuberger Launch New Tokenized Fixed Income Fund PRNewsWire
SECZ Stock news Securitize Q2 Earnings Call Highlights MarketBeat
SECZ Press release Securitize Reports Second Quarter 2026 Results PRNewsWire
SECZ Press release Securitize Becomes a Registered Investment Adviser PRNewsWire
SECZ Press release Securitize and Cantor Collaborate to Enable Onchain IPOs and Follow-On Offerings for Public Companies PRNewsWire
See more
FAQ

Questions about Securitize Corp.

What does Securitize Corp. do?
Securitize is a financial technology company that provides a platform for tokenizing real-world assets, enabling businesses to raise capital by issuing digital tokens on the blockchain. It operates a regulated end-to-end platform for the issuance, trading, and servicing of tokenized securities for top-tier asset managers like BlackRock and KKR. The company went public via a business combination with Cantor Equity Partners II.
What is SECZ's market cap?
Securitize Corp. (SECZ) is a listed stock with a live quote. The latest market cap on this page is $1.3B.
Where is Securitize Corp. headquartered?
Securitize Corp. is headquartered in Miami, FL.
How do I get SECZ news from the API?
Call GET /v1/news?tickers=SECZ. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does SECZ news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for SECZ, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the SECZ price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs